Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacific Biosciences of California

2.34
+0.400020.62%
Post-market: 2.350.0100+0.43%19:57 EDT
Volume:22.75M
Turnover:51.38M
Market Cap:702.87M
PE:-1.28
High:2.37
Open:2.07
Low:2.05
Close:1.94
52wk High:2.72
52wk Low:0.8511
Shares:300.37M
Float Shares:298.17M
Volume Ratio:2.28
T/O Rate:7.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8265
EPS(LYR):-1.1288
ROE:-189.96%
ROA:-33.28%
PB:11.43
PE(LYR):-2.07

Loading ...

Pacific Biosciences Q2 Adj. EPS $(0.13) Beats $(0.17) Estimate, Sales $39.766M Beat $36.886M Estimate

Benzinga
·
Aug 08

Pacific Biosciences of California Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
Aug 06

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

GlobeNewswire
·
Aug 04

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

GlobeNewswire
·
Jul 23

QIAGEN NV Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels for Enhanced Genomic Research

Reuters
·
Jul 23

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

GlobeNewswire
·
Jul 22

Pacific Biosciences Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Jun 25

Pacific Biosciences of California Inc. Conducted Annual Meeting

Reuters
·
Jun 07

BRIEF-PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

Reuters
·
May 22

Michele Farmer, Officer, Reports Disposal of Common Shares in Pacific Biosciences of California Inc

Reuters
·
May 22

Pacific Biosciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
May 16

Pacific Biosciences Price Target Maintained With a $1.80/Share by Stephens & Co.

Dow Jones
·
May 15

Pacific Biosciences of California Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Pacific Biosciences Q1 Adj. EPS $(0.15) Beats $(0.19) Estimate, Sales $37.15M Beat $34.81M Estimate

Benzinga
·
May 09

BRIEF-Pacific Biosciences of California Q1 Adjusted Gross Profit USD 15 Million

Reuters
·
May 09

Pacific Biosciences of California Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 07